Table of Contents Chapter 1 HIV Drugs Market Overview 1.1 HIV Drugs Definition 1.2 Global HIV Drugs Market Size Status and Outlook (2016-2030) 1.3 Global HIV Drugs Market Size Comparison by Region (2016-2030) 1.4 Global HIV Drugs Market Size Comparison by Type (2016-2030) 1.5 Global HIV Drugs Market Size Comparison by Application (2016-2030) 1.6 Global HIV Drugs Market Size Comparison by Sales Channel (2016-2030) 1.7 HIV Drugs Market Dynamics (COVID-19 Impacts) 1.7.1 Market Drivers/Opportunities 1.7.2 Market Challenges/Risks 1.7.3 Market News (Mergers/Acquisitions/Expansion) 1.7.4 COVID-19 Impacts 1.7.5 Post-Strategies of COVID-19 Chapter 2 HIV Drugs Market Segment Analysis by Player 2.1 Global HIV Drugs Sales and Market Share by Player (2019-2021) 2.2 Global HIV Drugs Revenue and Market Share by Player (2019-2021) 2.3 Global HIV Drugs Average Price by Player (2019-2021) 2.4 Players Competition Situation & Trends 2.5 Conclusion of Segment by Player Chapter 3 HIV Drugs Market Segment Analysis by Type 3.1 Global HIV Drugs Market by Type 3.1.1 Non-Nucleoside Reverse Transcriptase Inhibitors (NRTIs) 3.1.2 Nucleoside Reverse Transcriptase Inhibitors (NRTIs) 3.1.3 Multi-class Combination Drugs 3.1.4 Protease Inhibitors (PIs) 3.1.5 Others 3.2 Global HIV Drugs Sales and Market Share by Type (2016-2021) 3.3 Global HIV Drugs Revenue and Market Share by Type (2016-2021) 3.4 Global HIV Drugs Average Price by Type (2016-2021) 3.5 Leading Players of HIV Drugs by Type in 2021 3.6 Conclusion of Segment by Type Chapter 4 HIV Drugs Market Segment Analysis by Application 4.1 Global HIV Drugs Market by Application 4.1.1 Hospitals & Clinics 4.1.2 Retail Pharmacy 4.1.3 Online Pharmacy 4.2 Global HIV Drugs Revenue and Market Share by Application (2016-2021) 4.3 Leading Consumers of HIV Drugs by Application in 2021 4.4 Conclusion of Segment by Application Chapter 5 HIV Drugs Market Segment Analysis by Sales Channel 5.1 Global HIV Drugs Market by Sales Channel 5.1.1 Direct Channel 5.1.2 Distribution Channel 5.2 Global HIV Drugs Revenue and Market Share by Sales Channel (2016-2021) 5.3 Leading Distributors/Dealers of HIV Drugs by Sales Channel in 2021 5.4 Conclusion of Segment by Sales Channel Chapter 6 HIV Drugs Market Segment Analysis by Region 6.1 Global HIV Drugs Market Size and CAGR by Region (2016-2030) 6.2 Global HIV Drugs Sales and Market Share by Region (2016-2021) 6.3 Global HIV Drugs Revenue and Market Share by Region (2016-2021) 6.4 North America 6.4.1 North America Market by Country 6.4.2 North America HIV Drugs Market Share by Type 6.4.3 North America HIV Drugs Market Share by Application 6.4.4 United States 6.4.5 Canada 6.4.6 Mexico 6.5 Europe 6.5.1 Europe Market by Country 6.5.2 Europe HIV Drugs Market Share by Type 6.5.3 Europe HIV Drugs Market Share by Application 6.5.4 Germany 6.5.5 UK 6.5.6 France 6.5.7 Italy 6.5.8 Russia 6.5.9 Spain 6.6 Asia-Pacific 6.6.1 Asia-Pacific Market by Country 6.6.2 Asia-Pacific HIV Drugs Market Share by Type 6.6.3 Asia-Pacific HIV Drugs Market Share by Application 6.6.4 China 6.6.5 Japan 6.6.6 Korea 6.6.7 India 6.6.8 Southeast Asia 6.6.9 Australia 6.7 South America 6.7.1 South America Market by Country 6.7.2 South America HIV Drugs Market Share by Type 6.7.3 South America HIV Drugs Market Share by Application 6.7.4 Brazil 6.7.5 Argentina 6.7.6 Colombia 6.8 Middle East & Africa 6.8.1 Middle East & Africa Market by Country 6.8.2 Middle East & Africa HIV Drugs Market Share by Type 6.8.3 Middle East & Africa HIV Drugs Market Share by Application 6.8.4 UAE 6.8.5 Saudi Arabia 6.8.6 South Africa 6.9 Conclusion of Segment by Region Chapter 7 Profile of Leading HIV Drugs Players 7.1 Boehringer Ingelheim 7.1.1 Company Snapshot 7.1.2 Product/Service Offered 7.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share) 7.2 Merck 7.3 Pfizer 7.4 Gilead Sciences 7.5 GalaxoSmithKline 7.6 Johnson & Johnson 7.7 Roche 7.8 Teva Pharmaceutical 7.9 AbbVie 7.10 Cipla 7.11 Bristol-Myers Squibb 7.12 Mylan Chapter 8 Upstream and Downstream Analysis of HIV Drugs 8.1 Industrial Chain of HIV Drugs 8.2 Upstream of HIV Drugs 8.3 Downstream of HIV Drugs Chapter 9 Development Trend of HIV Drugs (2022-2030) 9.1 Global HIV Drugs Market Size (Sales and Revenue) Forecast (2022-2030) 9.2 Global HIV Drugs Market Size and CAGR Forecast by Region (2022-2030) 9.3 Global HIV Drugs Market Size and CAGR Forecast by Type (2022-2030) 9.4 Global HIV Drugs Market Size and CAGR Forecast by Application (2022-2030) 9.5 Global HIV Drugs Market Size and CAGR Forecast by Sales Channel (2022-2030) Chapter 10 Appendix 10.1 Research Methodology 10.2 Data Sources 10.3 Disclaimer 10.4 Analysts Certification

List of Tables and Figures Figure HIV Drugs Example Figure Global HIV Drugs Revenue (Million $) Status and Outlook (2016-2030) Figure Global HIV Drugs Revenue (Million $) Comparison by Region (2016-2030) Figure Global HIV Drugs Revenue (Million $) Comparison by Type (2016-2030) Figure Global HIV Drugs Revenue (Million $) Comparison by Application (2016-2030) Figure Global HIV Drugs Revenue (Million $) Comparison by Sales Channel (2016-2030) Table Global HIV Drugs Sales by Player (2019-2021) Table Global HIV Drugs Sales Market Share by Player (2019-2021) Figure Global HIV Drugs Sales Market Share by Player in 2021 Table Global HIV Drugs Revenue (Million $) by Player (2019-2021) Table Global HIV Drugs Revenue Market Share by Player (2019-2021) Figure Global HIV Drugs Revenue Market Share by Player in 2021 Table Global HIV Drugs Average Price by Player (2019-2021) Figure Global HIV Drugs Average Price by Player in 2021 Figure Global HIV Drugs Players Competition Situation – Top 5 Players’ Revenue Market Share in 2019 Figure Global HIV Drugs Players Competition Trends – Top 5 Players’ Revenue Market Share in 2021 Figure Example of Non-Nucleoside Reverse Transcriptase Inhibitors (NRTIs) Figure Global Non-Nucleoside Reverse Transcriptase Inhibitors (NRTIs) Revenue (Million $) and Growth Rate (2016-2021) Figure Example of Nucleoside Reverse Transcriptase Inhibitors (NRTIs) Figure Global Nucleoside Reverse Transcriptase Inhibitors (NRTIs) Revenue (Million $) and Growth Rate (2016-2021) Figure Example of Multi-class Combination Drugs Figure Global Multi-class Combination Drugs Revenue (Million $) and Growth Rate (2016-2021) Figure Example of Protease Inhibitors (PIs) Figure Global Protease Inhibitors (PIs) Revenue (Million $) and Growth Rate (2016-2021) Figure Example of Others Figure Global Others Revenue (Million $) and Growth Rate (2016-2021) Table Global HIV Drugs Sales by Type (2016-2021) Table Global HIV Drugs Sales Market Share by Type (2016-2021) Figure Global HIV Drugs Sales Market Share by Type in 2021 Table Global HIV Drugs Revenue (Million $) by Type (2016-2021) Table Global HIV Drugs Revenue Market Share by Type (2016-2021) Figure Global HIV Drugs Revenue Market Share by Type in 2021 Table Global HIV Drugs Average Price by Type (2016-2021) Figure Global HIV Drugs Average Price by Type in 2021 Table Leading Players of HIV Drugs by Type in 2021 Figure Example of Hospitals & Clinics Figure Global HIV Drugs for Hospitals & Clinics Revenue (Million $) and Growth Rate (2016-2021) Figure Example of Retail Pharmacy Figure Global HIV Drugs for Retail Pharmacy Revenue (Million $) and Growth Rate (2016-2021) Figure Example of Online Pharmacy Figure Global HIV Drugs for Online Pharmacy Revenue (Million $) and Growth Rate (2016-2021) Table Global HIV Drugs Sales by Application (2016-2021) Table Global HIV Drugs Sales Market Share by Application (2016-2021) Figure Global HIV Drugs Sales Market Share by Application in 2021 Table Leading Consumers of HIV Drugs by Application in 2021 Figure Example of Direct Channel Figure Global HIV Drugs for Direct Channel Revenue (Million $) and Growth Rate (2016-2021) Figure Example of Distribution Channel Figure Global HIV Drugs for Distribution Channel Revenue (Million $) and Growth Rate (2016-2021) Table Global HIV Drugs Revenue by Sales Channel (2016-2021) Table Global HIV Drugs Revenue Market Share by Sales Channel (2016-2021) Figure Global HIV Drugs Revenue Market Share by Sales Channel in 2021 Table Leading Distributors/Dealers of HIV Drugs by Sales Channel in 2021 Table Global HIV Drugs Market Size and CAGR by Region (2016-2030) Table Global HIV Drugs Sales by Region (2016-2021) Table Global HIV Drugs Sales Market Share by Region (2016-2021) Figure Global HIV Drugs Sales Market Share by Region in 2021 Table Global HIV Drugs Revenue (Million $) by Region (2016-2021) Table Global HIV Drugs Revenue Market Share by Region (2016-2021) Figure Global HIV Drugs Revenue Market Share by Region in 2021 Table North America HIV Drugs Sales by Country (2016-2021) Figure North America HIV Drugs Sales Market Share by Country (2016-2021) Table North America HIV Drugs Revenue by Country (2016-2021) Figure North America HIV Drugs Revenue Market Share by Country (2016-2021) Figure North America HIV Drugs Market Share by Type in 2021 Figure North America HIV Drugs Market Share by Application in 2021 Figure United States HIV Drugs Sales and Growth Rate (2016-2021) Figure United States HIV Drugs Revenue (Million $) and Growth Rate (2016-2021) Figure Canada HIV Drugs Sales and Growth Rate (2016-2021) Figure Canada HIV Drugs Revenue (Million $) and Growth Rate (2016-2021) Figure Mexico HIV Drugs Sales and Growth Rate (2016-2021) Figure Mexico HIV Drugs Revenue (Million $) and Growth Rate (2016-2021) Table Europe HIV Drugs Sales by Country (2016-2021) Figure Europe HIV Drugs Sales Market Share by Country (2016-2021) Table Europe HIV Drugs Revenue by Country (2016-2021) Figure Europe HIV Drugs Revenue Market Share by Country (2016-2021) Figure Europe HIV Drugs Market Share by Type in 2021 Figure Europe HIV Drugs Market Share by Application in 2021 Figure Germany HIV Drugs Sales and Growth Rate (2016-2021) Figure Germany HIV Drugs Revenue (Million $) and Growth Rate (2016-2021) Figure UK HIV Drugs Sales and Growth Rate (2016-2021) Figure UK HIV Drugs Revenue (Million $) and Growth Rate (2016-2021) Figure France HIV Drugs Sales and Growth Rate (2016-2021) Figure France HIV Drugs Revenue (Million $) and Growth Rate (2016-2021) Figure Italy HIV Drugs Sales and Growth Rate (2016-2021) Figure Italy HIV Drugs Revenue (Million $) and Growth Rate (2016-2021) Figure Russia HIV Drugs Sales and Growth Rate (2016-2021) Figure Russia HIV Drugs Revenue (Million $) and Growth Rate (2016-2021) Figure Spain HIV Drugs Sales and Growth Rate (2016-2021) Figure Spain HIV Drugs Revenue (Million $) and Growth Rate (2016-2021) Table Asia-Pacific HIV Drugs Sales by Country (2016-2021) Figure Asia-Pacific HIV Drugs Sales Market Share by Country (2016-2021) Table Asia-Pacific HIV Drugs Revenue by Country (2016-2021) Figure Asia-Pacific HIV Drugs Revenue Market Share by Country (2016-2021) Figure Asia-Pacific HIV Drugs Market Share by Type in 2021 Figure Asia-Pacific HIV Drugs Market Share by Application in 2021 Figure China HIV Drugs Sales and Growth Rate (2016-2021) Figure China HIV Drugs Revenue (Million $) and Growth Rate (2016-2021) Figure Japan HIV Drugs Sales and Growth Rate (2016-2021) Figure Japan HIV Drugs Revenue (Million $) and Growth Rate (2016-2021) Figure Korea HIV Drugs Sales and Growth Rate (2016-2021) Figure Korea HIV Drugs Revenue (Million $) and Growth Rate (2016-2021) Figure India HIV Drugs Sales and Growth Rate (2016-2021) Figure India HIV Drugs Revenue (Million $) and Growth Rate (2016-2021) Figure Southeast Asia HIV Drugs Sales and Growth Rate (2016-2021) Figure Southeast Asia HIV Drugs Revenue (Million $) and Growth Rate (2016-2021) Figure Australia HIV Drugs Sales and Growth Rate (2016-2021) Figure Australia HIV Drugs Revenue (Million $) and Growth Rate (2016-2021) Table South America HIV Drugs Sales by Country (2016-2021) Figure South America HIV Drugs Sales Market Share by Country (2016-2021) Table South America HIV Drugs Revenue by Country (2016-2021) Figure South America HIV Drugs Revenue Market Share by Country (2016-2021) Figure South America HIV Drugs Market Share by Type in 2021 Figure South America HIV Drugs Market Share by Application in 2021 Figure Brazil HIV Drugs Sales and Growth Rate (2016-2021) Figure Brazil HIV Drugs Revenue (Million $) and Growth Rate (2016-2021) Figure Argentina HIV Drugs Sales and Growth Rate (2016-2021) Figure Argentina HIV Drugs Revenue (Million $) and Growth Rate (2016-2021) Figure Colombia HIV Drugs Sales and Growth Rate (2016-2021) Figure Colombia HIV Drugs Revenue (Million $) and Growth Rate (2016-2021) Table Middle East & Africa HIV Drugs Sales by Country (2016-2021) Figure Middle East & Africa HIV Drugs Sales Market Share by Country (2016-2021) Table Middle East & Africa HIV Drugs Revenue by Country (2016-2021) Figure Middle East & Africa HIV Drugs Revenue Market Share by Country (2016-2021) Figure Middle East & Africa HIV Drugs Market Share by Type in 2021 Figure Middle East & Africa HIV Drugs Market Share by Application in 2021 Figure UAE HIV Drugs Sales and Growth Rate (2016-2021) Figure UAE HIV Drugs Revenue (Million $) and Growth Rate (2016-2021) Figure Saudi Arabia HIV Drugs Sales and Growth Rate (2016-2021) Figure Saudi Arabia HIV Drugs Revenue (Million $) and Growth Rate (2016-2021) Figure South Africa HIV Drugs Sales and Growth Rate (2016-2021) Figure South Africa HIV Drugs Revenue (Million $) and Growth Rate (2016-2021) Table Company Snapshot of Boehringer Ingelheim Table HIV Drugs Introduction of Boehringer Ingelheim Table HIV Drugs Sales, Price, Revenue, Gross Margin and Market Share of Boehringer Ingelheim (2019-2021) Table Industrial Chain of HIV Drugs Table Manufacturing Cost Structure of HIV Drugs Table General Manufacturing Process of HIV Drugs Table Leading Distributors/Dealers of HIV Drugs Table Leading Consumers of HIV Drugs Figure Global HIV Drugs Sales and Growth Rate Forecast (2022-2030) Figure Global HIV Drugs Revenue and Growth Rate Forecast (2022-2030) Table Global HIV Drugs Market Size and CAGR Forecast by Region (2022-2030) Table Global HIV Drugs Market Size and CAGR Forecast by Type (2022-2030) Table Global HIV Drugs Market Size and CAGR Forecast by Application (2022-2030) Table Global HIV Drugs Market Size and CAGR Forecast by Sales Channel (2022-2030)

Leading players of HIV Drugs including: Boehringer Ingelheim Merck Pfizer Gilead Sciences GalaxoSmithKline Johnson & Johnson Roche Teva Pharmaceutical AbbVie Cipla Bristol-Myers Squibb Mylan